Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1955 3
1957 1
1958 1
1960 1
1961 1
1962 1
1963 2
1964 1
1965 1
1966 2
1967 1
1969 2
1970 3
1972 2
1973 2
1974 1
1977 1
1980 3
1981 1
1982 4
1983 3
1984 4
1985 4
1988 4
1989 2
1990 8
1991 3
1992 7
1993 7
1994 3
1995 2
1996 2
1997 5
1998 3
1999 3
2000 5
2001 6
2002 2
2003 7
2004 6
2005 4
2006 12
2007 11
2008 11
2009 15
2010 16
2011 19
2012 19
2013 19
2014 28
2015 18
2016 21
2017 14
2018 13
2019 14
2020 29
2021 25
2022 20
2023 24
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

414 results

Results by year

Filters applied: . Clear all
Page 1
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. Among authors: novak z. N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972026 Clinical Trial.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. Among authors: novak z. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Reply.
Novak Z, Zaky A, Spangler EL, Beck AW. Novak Z, et al. J Vasc Surg. 2021 Dec;74(6):2122. doi: 10.1016/j.jvs.2021.08.063. J Vasc Surg. 2021. PMID: 34809823 Free article. No abstract available.
A humán papillomavírus okozta megbetegedések, megelőzésük lehetőségei és ennek népegészségügyi előnyei.
Kásler M, Ács N, Bata Z, Dankó D, Hernádi Z, Kálmán M, Kornya L, Kovács J, Mészáros G, Molnár MP, Mór Z, Novák Z, Sobel G, Szentirmay Z, Takács L, Tisza T. Kásler M, et al. Among authors: novak z. Orv Hetil. 2012 Dec 15;153 Suppl 4:1-39. doi: 10.1556/650.2012.0004. Orv Hetil. 2012. PMID: 26686555 Hungarian. No abstract available.
[Fertility preservation in female cancer patients.].
Vesztergom D, Nánássy L, Polgár C, Krádi A, Rosta V, Varga S, Novák Z. Vesztergom D, et al. Among authors: novak z. Orv Hetil. 2023 Jul 16;164(28):1094-1101. doi: 10.1556/650.2023.32823. Print 2023 Jul 16. Orv Hetil. 2023. PMID: 37454332 Review. Hungarian.
Neuroendoscopy.
Chrastina J, Novak Z, Riha I. Chrastina J, et al. Among authors: novak z. Bratisl Lek Listy. 2008;109(5):198-201. Bratisl Lek Listy. 2008. PMID: 18630801
Bilastine: a lifetime companion for the treatment of allergies.
Church MK, Tiongco-Recto M, Ridolo E, Novák Z. Church MK, et al. Among authors: novak z. Curr Med Res Opin. 2020 Mar;36(3):445-454. doi: 10.1080/03007995.2019.1681134. Epub 2019 Nov 13. Curr Med Res Opin. 2020. PMID: 31612732 Review.
414 results